Drugmakers put workflow friction, not model speed, at the center of AI returns
GSK, Genentech and Biogen leaders described measurable local gains while questioning whether faster tasks are shortening the path to treatment.
GSK, Genentech and Biogen leaders described measurable local gains while questioning whether faster tasks are shortening the path to treatment.
Syed Mohiuddin told Christina Farr that health AI can already help with administrative work. Acting for patients requires more complete records and stronger validation.
Lori Gottlieb and Sword Health’s Virgílio Bento discussed when AI could help people seek support and what clinicians bring to therapy.
Boston Children’s tested AI-assisted histories from the waiting room. The pilot examined usability and summary quality.
A nursing workshop asked what needs to change for nurses to help shape how AI tools fit their work.
A discharge summary can cost less to generate than to check for omissions. Stanford, Google and Abridge panelists examined what hospitals should count before signing a contract.
Jon Wang said Assort Health saw lower conversion as AI calls got longer and described giving scheduling agents access to open referrals.
Cigna’s workflow brings information together before patient outreach. OpenAI also described clinician review, access controls and the limits of its inbox-task evaluations.
Apple’s U.S. study will examine whether people understand and trust AI answers, and what happens when they choose to add data from their own health records and devices.
HLTH USA 2026 opened at the Venetian Expo in Las Vegas with artificial intelligence dominating the program, alongside questions of clinical validation, interoperability, costs and scale.
David Finn understands that good AI and data governance will be a key element in success going forward for the healthcare industry.
At HealthDataCon 2026, CMS CIO Patrick Newbold outlined how human control, reliable data and measurable outcomes should govern healthcare Super Intelligence, while describing fraud pilots and plans to tighten oversight of partner data use.